1. Alani H, Tamimi A, Tamimi N: Cardiovascular co-morbidity in chronic kidney disease: Current knowledge and future research needs. World J Nephrol 2014, 3:156-168.
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305.
3. Linton MRF, Yancey PG, Davies SS, Jerome WG, Linton EF, Song WL, Doran AC, Vickers KC: The Role of Lipids and Lipoproteins in Atherosclerosis. In Endotext. Edited by Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, et al. South Dartmouth (MA): MDText.com, Inc.; 2000
4. Upadhyay A, Earley A, Lamont JL, Haynes S, Wanner C, Balk EM: Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med 2012, 157:251-262.
5. Kennard A, Singer R: Lipid lowering in renal disease. Aust Prescr 2017, 40:141-146.
6. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GFM: HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database of Systematic Reviews 2013.
7. Aung T, Halsey J, Kromhout D, Gerstein HC, Marchioli R, Tavazzi L, Geleijnse JM, Rauch B, Ness A, Galan P, et al: Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77917 Individuals. JAMA Cardiol 2018, 3:225-234.
8. An WS, Lee SM, Son YK, Kim SE, Kim KH, Han JY, Bae HR, Rha SH, Park Y: Omega-3 fatty acid supplementation increases 1,25-dihydroxyvitamin D and fetuin-A levels in dialysis patients. Nutrition Research 2012, 32:495-502.
9. Asemi Z, Soleimani A, Bahmani F, Shakeri H, Mazroii N, Abedi F, Fallah M, Mohammadi AA, Esmaillzadeh A: Effect of the omega-3 fatty acid plus vitamin E supplementation on subjective global assessment score, glucose metabolism, and lipid concentrations in chronic hemodialysis patients. Molecular Nutrition & Food Research 2016, 60:390-398.
10. Ateya AM, Sabri NA, El Hakim I, Shaheen SM: Effect of Omega-3 Fatty Acids on Serum Lipid Profile and Oxidative Stress in Pediatric Patients on Regular Hemodialysis: A Randomized Placebo-Controlled Study. Journal of Renal Nutrition 2017, 27:169-174.
11. Bowden RG, Jitomir J, Wilson RL, Gentile M: Effects of Omega-3 Fatty Acid Supplementation on Lipid Levels in Endstage Renal Disease Patients. Journal of Renal Nutrition 2009, 19:259-266.
12. Daud ZA, Tubie B, Adams J, Quainton T, Osia R, Tubie S, Kaur D, Khosla P, Sheyman M: Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients. Vasc Health Risk Manag 2012, 8:187-195.
13. de Mattos AM, da Costa JAC, Jordao AA, Chiarello PG: Omega-3 Fatty Acid Supplementation is Associated With Oxidative Stress and Dyslipidemia, but Does not Contribute to Better Lipid and Oxidative Status on Hemodialysis Patients. Journal of Renal Nutrition 2017, 27:333-339.
14. Donnelly SM, Ali MAM, Churchill DN: Effect of N-3 Fatty-Acids from Fish Oil on Hemostasis, Blood-Pressure, and Lipid Profile of Dialysis Patients. Journal of the American Society of Nephrology 1992, 2:1634-1639.
15. Ewers B, Riserus U, Marckmann P: Effects of Unsaturated Fat Dietary Supplements on Blood Lipids, and on Markers of Malnutrition and Inflammation in Hemodialysis Patients. Journal of Renal Nutrition 2009, 19:401-411.
16. Gharekhani A, Dashti-Khavidaki S, Lessan-Pezeshki M, Khatami MR: Potential Effects of Omega-3 Fatty Acids on Insulin Resistance and Lipid Profile in Maintenance Hemodialysis Patients A Randomized Placebo-Controlled Trial. Iranian Journal of Kidney Diseases 2016, 10:310-318.
17. Jabbari M, Khoshnevis T, Jenabi A, Yousefi F: The Effect of Omega-3 Supplement on Serum Lipid Profile in Patients Undergoing Hemodialysis: A Randomized Clinical Trial. Rom J Intern Med 2016, 54:222-227.
18. Kajbaf MH, Khorvash F, Mortazavi M, Shahidi S, Moeinzadeh F, Farajzadegan Z, Tirani SA: Does Omega-3 supplementation decrease carotid intima-media thickening in hemodialysis patients? J Res Pharm Pract 2016, 5:252-256.
19. Khajehdehi P: Lipid-lowering effect of polyunsaturated fatty acids in hemodialysis patients. J Ren Nutr 2000, 10:191-195.
20. Khalatbari Soltani S, Jamaluddin R, Tabibi H, Mohd Yusof BN, Atabak S, Loh SP, Rahmani L: Effects of flaxseed consumption on systemic inflammation and serum lipid profile in hemodialysis patients with lipid abnormalities. Hemodialysis International 2013, 17:275-281.
21. Khosroshahi HT, Dehgan R, Asl BH, Safaian A, Panahi F, Estakhri R, Purasgar B: Effect of Omega-3 Supplementation on Serum Level of Homocysteine in Hemodialysis Patients. Iranian Journal of Kidney Diseases 2013, 7:479-484.
22. Kooshki A, Taleban FA, Tabibi H, Hedayati M: Effects of Omega-3 Fatty Acids on Serum Lipids, Lipoprotein (a), and Hematologic Factors in Hemodialysis Patients. Renal Failure 2011, 33:892-898.
23. Lee SM, Son YK, Kim SE, An WS: The Effects of Omega-3 Fatty Acid on Vitamin D Activation in Hemodialysis Patients: A Pilot Study. Marine Drugs 2015, 13:741-755.
24. Lemos JRN, de Alencastro MG, Konrath AV, Cargnin M, Manfro RC: Flaxseed oil supplementation decreases C-reactive protein levels in chronic hemodialysis patients. Nutrition Research 2012, 32:921-927.
25. Mirfatahi M, Imani H, Tabibi H, Nasrollahi A, Hedayatis M: Effects of Flaxseed Oil on Serum Bone Turnover Markers in Hemodialysis Patients A Randomized Controlled Trial. Iranian Journal of Kidney Diseases 2018, 12:215-222.
26. Mirfatahi M, Tabibi H, Nasrollahi A, Hedayati M, Taghizadeh M: Effect of flaxseed oil on serum systemic and vascular inflammation markers and oxidative stress in hemodialysis patients: a randomized controlled trial. International Urology and Nephrology 2016, 48:1335-1341.
27. Moeinzadeh F, Shahidi S, Mortazavi M, Dolatkhah S, Kajbaf M, Javanmard SH, Moghtaderi A: Effects of Omega-3 Fatty Acid Supplementation on Serum Biomarkers, Inflammatory Agents, and Quality of Life of Patients on Hemodialysis. Iranian Journal of Kidney Diseases 2016, 10:381-387.
28. Naini AE, Keyvandarian N, Mortazavi M, Taheri S, Hosseini SM: Effect of Omega-3 fatty acids on blood pressure and serum lipids in continuous ambulatory peritoneal dialysis patients. J Res Pharm Pract 2015, 4:135-141.
29. Omrani HR, Pasdar Y, Raisi D, Najafi F, Esfandiari A: The effect of omega-3 on serum lipid profile in hemodialysis patients. J Renal Inj Prev 2015, 4:68-72.
30. Rantanen JM, Riahi S, Johansen MB, Schmidt EB, Christensen JH: Effects of Marine n-3 Polyunsaturated Fatty Acids on Heart Rate Variability and Heart Rate in Patients on Chronic Dialysis: A Randomized Controlled Trial. Nutrients 2018, 10.
31. Saifullah A, Watkins BA, Saha C, Li Y, Moe SM, Friedman AN: Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients - A pilot study. Nephrology Dialysis Transplantation 2007, 22:3561-3567.
32. Sorensen GVB, Svensson M, Strandhave C, Schmidt EB, Jorgensen KA, Christensen JH: The Effect of n-3 Fatty Acids on Small Dense Low-Density Lipoproteins in Patients With End-Stage Renal Disease: A Randomized Placebo-Controlled Intervention Study. Journal of Renal Nutrition 2015, 25:376-380.
33. Svensson M, Frobert O, Schmidt EB, Jorgensen KA, Simonsen U, Christensen JH: The effect of n-3 fatty acids on levels of methylarginines in patients with end-stage renal disease. Journal of Nephrology 2010, 23:459-464.
34. Svensson M, Schmidt EB, Jorgensen KA, Christensen JH: N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: A randomized, placebo-controlled intervention trial. Clinical Journal of the American Society of Nephrology 2006, 1:780-786.
35. Svensson M, Schmidt EB, Jorgensen KA, Christensen JH: The effect of n-3 fatty acids on heart rate variability in patients treated with chronic hemodialysis. Journal of Renal Nutrition 2007, 17:243-249.
36. Svensson M, Schrnidt EB, Jorgense KA, Christensen JH: The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study. Nephrology Dialysis Transplantation 2008, 23:2918-2924.
37. Taziki O, Lessan-Pezeshki M, Akha O, Vasheghani F: The effect of low dose omega-3 on plasma lipids in hemodialysis patients. Saudi J Kidney Dis Transpl 2007, 18:571-576.
38. Chi HG, Lin XR, Huang HH, Zheng XB, Li T, Zou Y: Omega-3 Fatty Acid Supplementation on Lipid Profiles in Dialysis Patients: Meta-analysis. Archives of Medical Research 2014, 45:469-477.
39. Xu TH, Sun YT, Sun W, Yao L, Sun L, Liu LL, Ma JF, Wang LN: Effect of omega-3 fatty acid supplementation on serum lipids and vascular inflammation in patients with end-stage renal disease: a meta-analysis. Scientific Reports 2016, 6.
40. Wu PK, Yeh SC, Li SJ, Kang YN: Efficacy of polyunsaturated fatty acids on inflammatory markers in patients undergoing dialysis: A systematic review with network meta-analysis of randomized clinical trials. International Journal of Molecular Sciences 2019, 20.
41. Beavers KM, Beavers DP, Bowden RG, Wilson RL, Gentile M: Effect of Over-the-Counter Fish-Oil Administration on Plasma Lp(a) Levels in an End-Stage Renal Disease Population. Journal of Renal Nutrition 2009, 19:443-449.
42. Begum R, Belury MA, Burgess JR, Peck LW: Supplementation with N-3 and N-6 polyunsaturated fatty acids: Effects on lipoxygenase activity and clinical symptoms of pruritus in hemodialysis patients. Journal of Renal Nutrition 2004, 14:233-241.
43. Poulia KA, Panagiotakos DB, Tourlede E, Rezou A, Stamatiadis D, Boletis J, Zampelas A: Omega-3 Fatty Acids Supplementation Does Not Affect Serum Lipids in Chronic Hemodialysis Patients. Journal of Renal Nutrition 2011, 21:479-484.
44. Kunutsor SK, Zaccardi F, Karppi J, Kurl S, Laukkanen JA: Is High Serum LDL/HDL Cholesterol Ratio an Emerging Risk Factor for Sudden Cardiac Death? Findings from the KIHD Study. Journal of Atherosclerosis and Thrombosis 2017, 24:600-608.
45. Yokokawa H, Yasumura S, Tanno K, Ohsawa M, Onoda T, Itai K, Sakata K, Kawamura K, Tanaka F, Yoshida Y, et al: Serum Low-Density Lipoprotein to High-Density Lipoprotein Ratio as a Predictor of Future Acute Myocardial Infarction Among Men in a 2.7-Year Cohort Study of a Japanese Northern Rural Population. Journal of Atherosclerosis and Thrombosis 2011, 18:89-98.
46. Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP, et al: The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 2015, 162:777-784.
47. Hozo SP, Djulbegovic B, Hozo I: Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005, 5:13.
48. Baigent C, Burbury K, Wheeler D: Premature cardiovascular disease in chronic renal failure. The Lancet 2000, 356:147-152.
49. Bayés B, Pastor MC, Bonal J, Foraster A, Romero R: Oxidative stress, inflammation and cardiovascular mortality in haemodialysis—role of seniority and intravenous ferrotherapy: analysis at 4 years of follow-up. Nephrology Dialysis Transplantation 2005, 21:984-990.
50. Mikolasevic I, Žutelija M, Mavrinac V, Orlic L: Dyslipidemia in patients with chronic kidney disease: etiology and management. International journal of nephrology and renovascular disease 2017, 10:35-45.
51. Kumar S, Bogle R, Banerjee D: Why do young people with chronic kidney disease die early? World journal of nephrology 2014, 3:143-155.
52. Maki KC, Eren F, Cassens ME, Dicklin MR, Davidson MH: ω-6 Polyunsaturated Fatty Acids and Cardiometabolic Health: Current Evidence, Controversies, and Research Gaps. Advances in Nutrition 2018, 9:688-700.
53. Hooper L, Al-Khudairy L, Abdelhamid AS, Rees K, Brainard JS, Brown TJ, Ajabnoor SM, O'Brien AT, Winstanley LE, Donaldson DH, et al: Omega-6 fats for the primary and secondary prevention of cardiovascular disease. The Cochrane database of systematic reviews 2018, 7:CD011094-CD011094.
54. Makni M, Fetoui H, Gargouri N, Garoui EM, Jaber H, Makni J, Boudawara T, Zeghal N: Hypolipidemic and hepatoprotective effects of flax and pumpkin seed mixture rich in ω-3 and ω-6 fatty acids in hypercholesterolemic rats. Food and Chemical Toxicology 2008, 46:3714-3720.
55. Mensink RP, Organization WH: Effects of saturated fatty acids on serum lipids and lipoproteins: a systematic review and regression analysis. 2016.
56. Panth N, Abbott KA, Dias CB, Wynne K, Garg ML: Differential effects of medium-and long-chain saturated fatty acids on blood lipid profile: a systematic review and meta-analysis. The American journal of clinical nutrition 2018, 108:675-687.
57. Arunima S, Rajamohan T: Virgin coconut oil improves hepatic lipid metabolism in rats–compared with copra oil, olive oil and sunflower oil. 2012.
58. Lee E-J, Oh H, Kang BG, Kang M-K, Kim DY, Kim Y-H, Lee JY, Ji JG, Lim SS, Kang Y-H: Lipid-lowering effects of medium-chain triglyceride-enriched coconut oil in combination with licorice extracts in experimental hyperlipidemic mice. Journal of agricultural and food chemistry 2018, 66:10447-10457.
59. Mune M, Yukawa S, Kishino M, Otani H, Kimura K, Nishikawa O, Takahashi T, Kodama N, Saika Y, Yamada Y: Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients. Kidney International 1999, 56:S126-S129.
60. Marques de Mattos A, Marino LV, Ovidio PP, Jordão AA, Almeida CC, Chiarello PG: Protein oxidative stress and dyslipidemia in dialysis patients. Therapeutic Apheresis and Dialysis 2012, 16:68-74.
61. Wratten ML, Galaris D, Tetta C, Sevanian A: Evolution of oxidative stress and inflammation during hemodialysis and their contribution to cardiovascular disease. Antioxidants and Redox Signaling 2002, 4:935-944.
62. Huang J, Yi B, Li A-m, Zhang H: Effects of vitamin E-coated dialysis membranes on anemia, nutrition and dyslipidemia status in hemodialysis patients: a meta-analysis. Renal failure 2015, 37:398-407.
63. Mafra D, Santos FR, Lobo JC, de Mattos Grosso D, Barreira AL, Velarde LGC, Abdalla DSP, Leite Jr M: Alpha-tocopherol supplementation decreases electronegative low-density lipoprotein concentration [LDL (−)] in haemodialysis patients. Nephrology Dialysis Transplantation 2009, 24:1587-1592.
64. Saglimbene VM, Wong G, van Zwieten A, Palmer SC, Ruospo M, Natale P, Campbell K, Teixeira-Pinto A, Craig JC, Strippoli GFM: Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials. Clin Nutr 2019.